Grant round · GrantConnect grant opportunity
Grant round GO7567
Awards in this round describe their activity in more than one way. The most common:
- “A first-in-class oral peptide therapy for chronic visceral pain (CVP) in irritable bowel syndrome (IBS)” (1 award)
- “Abdominal Vagus Nerve Stimulation - Side-effect free seizure reduction” (1 award)
- “Advancing a first-in-class therapy for the treatment of advanced and refractory prostate cancer” (1 award)
- “DaWinCI - Cochlear drug delivery for flexible treatment of inner ear disease” (1 award)
- “Developing novel polymer-based haemostatic sealants for trauma and surgical bleeding” (1 award)
$17m
whole-of-term value of 15 awards to 9 named recipients, published 2026-01-19 to 2026-01-19
$6.3m falls in 2026-27, from 15 active awards. estimate: annualised
A grant round is a grant opportunity on GrantConnect: an open or targeted call for applications under published guidelines. GrantConnect’s award lists give the opportunity’s ID but not its title; search GrantConnect for GO7567 to read its guidelines.
By agency
| Granting agency | Awards | Total value |
|---|---|---|
| National Health and Medical Research Council (NHMRC) | 15 | $17m |
Recipients, largest first
Recipients who are individuals, and awards that name no single recipient, are counted above but not listed, here or in the CSV. Why The bulk download has every award, with individuals flagged.
| Recipient | Awards | Total value |
|---|---|---|
| University of Melbourne | 5 | $6.1m |
| Monash University | 2 | $2.2m |
| The University of Queensland | 2 | $2.2m |
| The Walter and Eliza Hall Institute of Medical Research | 1 | $1.6m |
| University of New South Wales | 1 | $1.2m |
| The Bionics Institute of Australia | 1 | $1.2m |
| South Australian Health and Medical Research Institute Limited | 1 | $1.1m |
| Griffith University | 1 | $918k |
| University of Sydney | 1 | $644k |